Fredun Pharmaceuticals Ltd — Updates, 30-05-2025: Company Update

Fredun Pharmaceuticals reported full compliance with all applicable secretarial standards and timely adoption of board-approved policies during the review period. The company addressed earlier lapses related to delayed appointments of independent directors on key committees by promptly regularizing the board composition and paying applicable fines. A previous non-compliance regarding auditors’ peer review certificates was resolved by appointing M/s. R.H. Nisar & Co., holding a valid certificate. Minor delays occurred in applying for trading approvals following warrant conversions, attributed to corporate action processes and technical issues, but were rectified. No disqualifications of directors or significant regulatory actions were noted.